Association of serum D-dimer levels with disease activity in chronic urticaria, psoriasis and urticarial vasculitis

A. K. M. Reajaul Haque; Sharmin Begum; Tawfique R. Islam; M. Shakhawat Hossain; Babu R. Mandal; Fatma Shahjahan; Rubaiya N. Lopa; Nayan C. Shyam

doi:10.18203/2320-6012.ijrms20262607

Authors

A. K. M. Reajaul Haque Department of Dermatology and Venereology, Bangladesh Medical University, Dhaka, Bangladesh
Sharmin Begum Department of Dermatology and Venereology, Bangladesh Medical University, Dhaka, Bangladesh
Tawfique R. Islam Department of Dermatology and Venereology, Bangladesh Medical University, Dhaka, Bangladesh
M. Shakhawat Hossain Department of Dermatology and Venereology, Shaheed Suhrawardy Medical College Hospital, Dhaka, Bangladesh
Babu R. Mandal Department of Dermatology and Venereology, Bangladesh Medical University, Dhaka, Bangladesh
Fatma Shahjahan Department of Dermatology and Venereology, Bangladesh Medical University, Dhaka, Bangladesh
Rubaiya N. Lopa Department of Dermatology and Venereology, Bangladesh Medical University, Dhaka, Bangladesh
Nayan C. Shyam Department of Dermatology, Prime Hospital Ltd, Noakhali, Bangladesh

DOI:

https://doi.org/10.18203/2320-6012.ijrms20262607

Keywords:

Chronic urticaria, Psoriasis, Urticarial vasculitis, Disease activity, Biomarker, Inflammation

Abstract

Background: Chronic urticaria, psoriasis and urticarial vasculitis are common skin inflammatory diseases that frequently have systemic implications. D-dimers in serum, as a coagulation activation marker, have been suggested as biomarkers for systemic inflammation in different autoimmune diseases. Its use for the evaluation of disease activity in chronic urticaria, psoriasis and urticarial vasculitis is not well established but there are no data available on the same especially in South Asian countries like Bangladesh. There is an association between serum D-dimer level and the severity of chronic urticaria, psoriasis and urticarial vasculitis, indicating its consideration as a biomarker for activity or response to therapy.

Methods: A hospital-based cross-sectional study was carried out in 100 patients with chronic urticaria, psoriasis or urticarial vasculitis. The severity of the diseases was evaluated by UAS7 for chronic urticaria, PASI test in psoriasis and clinical evaluation in prematurely aged urticarial vasculitis. Serum D-dimer was detected and statistical analysis, consisting of one-way ANOVA and Pearson/Spearman correlation test, was executed.

Results: The D-dimer levels were higher in all groups, the highest of which was found for the patients with urticarial vasculitis 59.7 ng/ml), whereas they were 512.4 ng/ml and 468.9 ng/ml for those with chronic urticaria and psoriasis, respectively. D-dimer levels were positively correlated with the severity of disease in all conditions to a considerable extent (p<0.001).

Conclusions: Serum D-dimer level is associated with the severity of chronic urticaria, psoriasis and urticarial vasculitis, and thus may be considered as a potential biomarker for evaluating disease activity or treatment response.

References

Kaplan AP, Greaves M. Pathogenesis of chronic urticaria. Clin Exp Allergy. 2009;39(6):777-87.

Boehncke WH, Schön MP. Psoriasis. Lancet. 2015;386(9997):983-94.

Zuberbier T, Aberer W, Asero R, Abdul Latiff AH, Baker D, Ballmer-Weber B, et al. The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2018;73(7):1393-414.

Parisi R, Symmons DPM, Griffiths CEM, Ashcroft DM. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133(2):377-85.

Kolkhir P, Grakhova M, Pereverzina N, Krause K, Maurer M. Urticarial vasculitis and urticarial autoinflammatory diseases. J Allergy Clin Immunol. 2019;143(3):873-87.

Lip GYH, Chin BS, Blann AD. Cancer and the prothrombotic state. Lancet Oncol. 2007;3(1):27-34.

Levi M, van der Poll T, Schultz M. Systemic inflammation and coagulation. Semin Thromb Hemost. 2012;38(8):823-31.

Takeda T, Sakurai Y, Takahagi S, Kamegashira A, Shindo H, Hide M, et al. Increase of coagulation potential in chronic spontaneous urticaria. Allergy. 2010;65(4):428-33.

Ahlehoff O, Gislason GH, Charlot M, Jørgensen CH, Lindhardsen J, Olesen JB, et al. Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. J Intern Med. 2015;277(4):447-55.

Wisnieski JJ. Urticarial vasculitis. Curr Opin Rheumatol. 2000;12(1):24-31.

Rahman M, Chowdhury MAJ, Islam MS. Epidemiological trends of dermatological diseases in Bangladesh. J Public Health Dev Ctries. 2020;6(2):112-9.

Gisondi P, Farina S, Giordano MV, Girolomoni G, Sala F. Usefulness of D-dimer as a biomarker of systemic inflammation in patients with psoriasis. J Eur Acad Dermatol Venereol. 2014;28(6):718-22.

Asero R, Tedeschi A, Riboldi P. Severe chronic urticaria is associated with elevated plasma levels of D-dimer. J Allergy Clin Immunol. 2007;120(3):672-4.

Ahmed S, Rahman MM, Hossain MA. Clinical patterns and severity of chronic urticaria in a tertiary care hospital. Bangladesh J Dermatol Venereol Leprol. 2021;38(1):15-21.

Esmon CT. The impact of the inflammatory response on coagulation. Thromb Res. 2004;114(5–6):321-7.